Safety and efficacy of BAY 94–9027, an extended-half-life factor VIII, during minor surgical procedures in patients with severe haemophilia A

Elena Santagostino; Shadan Lalezari; Mark T. Reding; Jonathan Ducore; Heng Joo Ng; Lone H. Poulsen; Lisa A. Michaels; Camila Linardi

doi:10.1111/hae.14319

Safety and efficacy of BAY 94–9027, an extended-half-life factor VIII, during minor surgical procedures in patients with severe haemophilia A

Elena Santagostino, Shadan Lalezari, Mark T. Reding, Jonathan Ducore, Heng Joo Ng, Lone H. Poulsen, Lisa A. Michaels, Camila Linardi

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	e559-e562
Journal	Haemophilia
Volume	27
Issue number	4
Early online date	May 3 2021
DOIs	https://doi.org/10.1111/hae.14319
State	Published - Jul 2021

Bibliographical note

Funding Information:
Elena Santagostino has participated in speaker bureaux and advisory boards from Bayer, Shire/Takeda, CSL Behring, Novo Nordisk, Roche, Grifols, Kedrion, Octapharma, Pfizer, UniQure, Spark, Sobi and Bioverativ. Shadan Lalezari has participated in advisory boards for Bayer and received honoraria or consultation fees from Bayer, Teva Pharmaceuticals, Takeda, PI Healthcare, Roche and Pfizer. Mark T. Reding has received institutional research support from Bayer and BioMarin and has participated in advisory boards and speaker bureaux for Bayer, Novo Nordisk, Sanofi Genzyme and Takeda. Jonathan Ducore has received honoraria or consultation fees from Octapharma, Bayer, Shire and HEMA Biologics; and speaking or presenting fees from Bayer and HEMA Biologics. Heng Joo Ng has nothing to disclose. Lone H. Poulsen has received grants and research support from Pfizer and has supported Bayer, Novo Nordisk, Sobi, Pfizer and Octapharma with congresses. Lisa A. Michaels was an employee of Bayer at the time of manuscript submission. Camila Linardi is an employee of Bayer.

Keywords

PEGylation
clinical outcome
clinical trials
extended half-life
factor VIII
haemophilia A
minor surgery

Publisher link

10.1111/hae.14319License: CC BY-NC-ND

Find It

Find It at U of M Libraries

Cite this

@article{3c626a0955564b73bbbf41278bf82c71,

title = "Safety and efficacy of BAY 94–9027, an extended-half-life factor VIII, during minor surgical procedures in patients with severe haemophilia A",

keywords = "PEGylation, clinical outcome, clinical trials, extended half-life, factor VIII, haemophilia A, minor surgery",

author = "Elena Santagostino and Shadan Lalezari and Reding, {Mark T.} and Jonathan Ducore and Ng, {Heng Joo} and Poulsen, {Lone H.} and Michaels, {Lisa A.} and Camila Linardi",

note = "Funding Information: Elena Santagostino has participated in speaker bureaux and advisory boards from Bayer, Shire/Takeda, CSL Behring, Novo Nordisk, Roche, Grifols, Kedrion, Octapharma, Pfizer, UniQure, Spark, Sobi and Bioverativ. Shadan Lalezari has participated in advisory boards for Bayer and received honoraria or consultation fees from Bayer, Teva Pharmaceuticals, Takeda, PI Healthcare, Roche and Pfizer. Mark T. Reding has received institutional research support from Bayer and BioMarin and has participated in advisory boards and speaker bureaux for Bayer, Novo Nordisk, Sanofi Genzyme and Takeda. Jonathan Ducore has received honoraria or consultation fees from Octapharma, Bayer, Shire and HEMA Biologics; and speaking or presenting fees from Bayer and HEMA Biologics. Heng Joo Ng has nothing to disclose. Lone H. Poulsen has received grants and research support from Pfizer and has supported Bayer, Novo Nordisk, Sobi, Pfizer and Octapharma with congresses. Lisa A. Michaels was an employee of Bayer at the time of manuscript submission. Camila Linardi is an employee of Bayer. ",

year = "2021",

month = jul,

doi = "10.1111/hae.14319",

language = "English (US)",

volume = "27",

pages = "e559--e562",

journal = "Haemophilia",

issn = "1351-8216",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

TY - JOUR

T1 - Safety and efficacy of BAY 94–9027, an extended-half-life factor VIII, during minor surgical procedures in patients with severe haemophilia A

AU - Santagostino, Elena

AU - Lalezari, Shadan

AU - Reding, Mark T.

AU - Ducore, Jonathan

AU - Ng, Heng Joo

AU - Poulsen, Lone H.

AU - Michaels, Lisa A.

AU - Linardi, Camila

N1 - Funding Information: Elena Santagostino has participated in speaker bureaux and advisory boards from Bayer, Shire/Takeda, CSL Behring, Novo Nordisk, Roche, Grifols, Kedrion, Octapharma, Pfizer, UniQure, Spark, Sobi and Bioverativ. Shadan Lalezari has participated in advisory boards for Bayer and received honoraria or consultation fees from Bayer, Teva Pharmaceuticals, Takeda, PI Healthcare, Roche and Pfizer. Mark T. Reding has received institutional research support from Bayer and BioMarin and has participated in advisory boards and speaker bureaux for Bayer, Novo Nordisk, Sanofi Genzyme and Takeda. Jonathan Ducore has received honoraria or consultation fees from Octapharma, Bayer, Shire and HEMA Biologics; and speaking or presenting fees from Bayer and HEMA Biologics. Heng Joo Ng has nothing to disclose. Lone H. Poulsen has received grants and research support from Pfizer and has supported Bayer, Novo Nordisk, Sobi, Pfizer and Octapharma with congresses. Lisa A. Michaels was an employee of Bayer at the time of manuscript submission. Camila Linardi is an employee of Bayer.

PY - 2021/7

Y1 - 2021/7

KW - PEGylation

KW - clinical outcome

KW - clinical trials

KW - extended half-life

KW - factor VIII

KW - haemophilia A

KW - minor surgery

UR - http://www.scopus.com/inward/record.url?scp=85105016869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85105016869&partnerID=8YFLogxK

U2 - 10.1111/hae.14319

DO - 10.1111/hae.14319

M3 - Letter

C2 - 33939226

AN - SCOPUS:85105016869

SN - 1351-8216

VL - 27

SP - e559-e562

JO - Haemophilia

JF - Haemophilia

IS - 4

ER -

Safety and efficacy of BAY 94–9027, an extended-half-life factor VIII, during minor surgical procedures in patients with severe haemophilia A

Bibliographical note

Keywords

Publisher link

Find It

Other files and links

Cite this